For instance, bcr-ABL fusion protein is the hallmark product of a genetic aberration that leads to constitutively active ABL1 kinase in chronic myeloid leukemia (CML) patients. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.